mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
1 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
1 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
1 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |